SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000299
Filing Date
2021-03-02
Accepted
2021-03-01 21:05:41
Documents
13
Period of Report
2021-02-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620325_8k-adma.htm   iXBRL 8-K 36317
  Complete submission text file 0001193805-21-000299.txt   260676

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20210225.xsd EX-101.SCH 3920
3 XBRL TAXONOMY EXTENSION DEFINITION adma-20210225_def.xml EX-101.DEF 28250
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20210225_lab.xml EX-101.LAB 37114
5 XBRL TAXONOMY EXTENSION PRESENTATION adma-20210225_pre.xml EX-101.PRE 26875
6 EXTRACTED XBRL INSTANCE DOCUMENT e620325_8k-adma_htm.xml XML 5328
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

IRS No.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 21700869
SIC: 2836 Biological Products, (No Diagnostic Substances)